Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »SEARCH RESULT
Is the Planning Commission out of touch with reality, or are we not listening? by Arun Maira
What has changed since the economic reforms began? Many things. No waiting for years for a telephone connection, now cell phones with everyone. From three makes of cars with wind-down windows to dozens of makes, all air-conditioned. From one domestic airline, government owned and for the rich, to many private carriers for the middle class too. What has also changed is the knocking on the window. There are many more rich people...
More »Pinki Virani author-activist interviewed by R Krithika
India is finally ready with a comprehensive Bill that will protect children from sexual abuse. But the Bill, says author-activist Pinki Virani, has a major flaw regarding sexual consent that needs to be immediately addressed and the stakeholders consulted before it becomes law. With a certain Standing Committee so much in the news, let us look at what is happening with another Standing Committee looking into a Bill to protect children...
More »Feeding the world requires "a new paradigm” by Jessica Dacey
Agriculture specialists convening in Bern to debate the question of how to feed the world have agreed on one thing: a new paradigm is needed. Farming models are breaking down – as witnessed by the suicide of a farmer every half hour in India - and new directions for research in agriculture for development are needed to support the sector and combat global poverty. A joint conference hosted by non-government organisation Swissaid...
More »Bitter pill for Big Pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »